Overview
Hypertrophic cardiomyopathy (HCM) is a common heart condition affecting approximately 1 in 500 people worldwide. It is characterized by the thickening of the heart muscle, particularly in the left ventricle, which can lead to impaired heart function and increased risk of sudden cardiac death. HCM is often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. The thickened heart muscle can obstruct blood flow, leading to symptoms such as chest pain, shortness of breath, and fainting.HCM can be caused by various genetic mutations, with the most common being in the MYBPC3 and MYH7 genes. These mutations affect the structure and function of the heart muscle, leading to its thickening. The condition can be diagnosed through a combination of physical examination, electrocardiogram (ECG), echocardiogram, and cardiac MRI. Treatment options for HCM include medications to reduce symptoms, implantable cardioverter-defibrillators (ICDs) to prevent sudden cardiac death, and in some cases, surgical interventions such as septal myectomy or alcohol septal ablation.
History/Background
The first description of HCM dates back to 1958, when it was described as "idiopathic hypertrophic subaortic stenosis" by American cardiologist Dr. L. Geoffrey Cooley. However, it wasn't until the 1980s that the genetic basis of the condition was discovered. Since then, numerous studies have shed light on the genetic mutations underlying HCM, leading to improved diagnostic and treatment options.Key Information
Key facts about HCM include:* It is the leading cause of sudden cardiac death in young athletes.
* It affects approximately 1 in 500 people worldwide.
* It is often inherited in an autosomal dominant pattern.
* The most common genetic mutations are in the MYBPC3 and MYH7 genes.
* Treatment options include medications, ICDs, and surgical interventions.
* Early diagnosis and treatment can significantly improve outcomes.
